share_log

乐普医疗(300003.SZ)拟斥不超2亿元参设医疗产业并购基金苏州乐朴

Lepu Medical Technology (300003.SZ) plans to invest no more than 0.2 billion yuan to participate in the establishment of a healthcare industry merger and acquisition Fund in Suzhou.

Zhitong Finance ·  Dec 31, 2024 12:51

Lepu Medical Technology (300003.SZ) announced that the company has cooperated with the professional investment institution Suzhou Lepu Suwing Consulting Partnership (has...

According to the Zhituo Finance APP, Lepu Medical Technology (300003.SZ) announced that the company, together with the professional investment institution Suzhou Lepu Suy Wing Consulting Partnership (Limited Partnership) (referred to as "Lepu Suy Wing") and other limited partners, has invested to establish the Suzhou Lepu Suy Wing Private Equity Partnership (Limited Partnership) (the specific name is subject to industrial and commercial registration, referred to as "Suzhou Lepu" or the partnership). The total fundraising scale of the Fund is RMB 1 billion, of which the company plans to use its own funds not exceeding RMB 0.2 billion. After the establishment of Suzhou Lepu, Lepu Suy Wing will be its general partner/executive partner, and will hire Suzhou Yip Wing Private Equity Fund Management Co., Ltd. (referred to as "Yip Wing Investment") to serve as the manager.

The fund is positioned as a merger and acquisition fund for the Medical Industry, mainly investing in medical instruments, Medical Services and other related industries, focusing primarily on related industries such as medical instruments and Medical Devices, with pharmaceuticals and Medical Services as supplementary sectors; the investment stage mainly includes growth-stage projects, supplemented by mature or early-stage projects. Currently, the market is in a downturn, and the company hopes to build an innovative ecological chain for the medical industry, fully integrating various resources to form synergistic effects to respond to market challenges, promote the integration of the company's industry resources, achieve optimization and upgrading of the business structure, and continuously maintain the company's leading advantage in the medical field.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment